JP2019508486A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019508486A5 JP2019508486A5 JP2018557200A JP2018557200A JP2019508486A5 JP 2019508486 A5 JP2019508486 A5 JP 2019508486A5 JP 2018557200 A JP2018557200 A JP 2018557200A JP 2018557200 A JP2018557200 A JP 2018557200A JP 2019508486 A5 JP2019508486 A5 JP 2019508486A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- disease
- agent according
- individual
- inflammatory bowel
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 8
- 208000018522 Gastrointestinal disease Diseases 0.000 claims description 6
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims description 6
- 230000002757 inflammatory effect Effects 0.000 claims description 6
- 208000010643 digestive system disease Diseases 0.000 claims description 5
- 208000018685 gastrointestinal system disease Diseases 0.000 claims description 5
- 210000001072 colon Anatomy 0.000 claims description 4
- 241001608234 Faecalibacterium Species 0.000 claims description 3
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims 11
- 239000003795 chemical substances by application Substances 0.000 claims 7
- 206010009900 Colitis ulcerative Diseases 0.000 claims 2
- 208000011231 Crohn disease Diseases 0.000 claims 2
- 201000006704 Ulcerative Colitis Diseases 0.000 claims 2
- 235000015872 dietary supplement Nutrition 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 208000002389 Pouchitis Diseases 0.000 claims 1
- 235000013361 beverage Nutrition 0.000 claims 1
- 230000001332 colony forming effect Effects 0.000 claims 1
- 235000013365 dairy product Nutrition 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 235000013373 food additive Nutrition 0.000 claims 1
- 239000002778 food additive Substances 0.000 claims 1
- 235000013376 functional food Nutrition 0.000 claims 1
- 239000002417 nutraceutical Substances 0.000 claims 1
- 235000021436 nutraceutical agent Nutrition 0.000 claims 1
- 241000894006 Bacteria Species 0.000 description 2
- 230000002265 prevention Effects 0.000 description 1
- 241000894007 species Species 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1650567 | 2016-01-25 | ||
| FR1650567A FR3046934B1 (fr) | 2016-01-25 | 2016-01-25 | Souche de faecalibacterium prausnitzii cncm i-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale |
| PCT/EP2017/051306 WO2017129515A1 (fr) | 2016-01-25 | 2017-01-23 | Souche de faecalibacterium prausnitzii cncm 1-4573 pour le traitement et la prevention d'une inflammation gastro-intestinale |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019508486A JP2019508486A (ja) | 2019-03-28 |
| JP2019508486A5 true JP2019508486A5 (enExample) | 2020-02-13 |
| JP6935632B2 JP6935632B2 (ja) | 2021-09-15 |
Family
ID=55862967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018557200A Active JP6935632B2 (ja) | 2016-01-25 | 2017-01-23 | 胃腸炎の処置及び予防のためのフィーカリバクテリウム・プラウスニッツィｃｎｃｍ ｉ−４５７３株 |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10918678B2 (enExample) |
| EP (1) | EP3407902B1 (enExample) |
| JP (1) | JP6935632B2 (enExample) |
| CN (1) | CN109310714A (enExample) |
| AU (1) | AU2017211244B2 (enExample) |
| CA (1) | CA3012214C (enExample) |
| ES (1) | ES2820338T3 (enExample) |
| FR (1) | FR3046934B1 (enExample) |
| HU (1) | HUE050810T2 (enExample) |
| IL (1) | IL260752B (enExample) |
| LT (1) | LT3407902T (enExample) |
| NZ (1) | NZ744528A (enExample) |
| PL (1) | PL3407902T3 (enExample) |
| PT (1) | PT3407902T (enExample) |
| SG (1) | SG11201806361PA (enExample) |
| WO (1) | WO2017129515A1 (enExample) |
| ZA (1) | ZA201805302B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10010412B2 (en) * | 2011-07-27 | 2018-07-03 | Edwards Lifesciences Corporation | Conical crimper |
| TWI778083B (zh) * | 2017-06-16 | 2022-09-21 | 日商表飛鳴製藥股份有限公司 | 脂肪關連疾患及/或炎症的預防或治療劑 |
| FR3084255B1 (fr) * | 2018-07-26 | 2020-07-03 | Institut National De La Recherche Agronomique (Inra) | Souche de streptococcus thermophilus cnrz160 pour le traitement et la prevention de l'inflammation intestinale et des desordres associes, chez un individu |
| FR3099053B1 (fr) * | 2019-07-24 | 2023-01-20 | Inst Nat De La Rech Agronomique Inra | Souches bacteriennes pour le traitement et la prevention d’une inflammation gastro-intestinale |
| EP3838276A1 (en) | 2019-12-17 | 2021-06-23 | Exeliom Biosciences | Association of faecalibacterium prausnitzii strain cncm i-4573 with pentasa® for the treatment and prevention of gastrointestinal inflammation |
| KR102169795B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 eb-fpdk9 균주 및 그의 용도 |
| KR102169794B1 (ko) * | 2020-06-24 | 2020-10-27 | 주식회사 엔테로바이옴 | 신규한 피칼리박테리움 프로스니치 균주 eb-fpdk11 및 그의 용도 |
| EP4180051A4 (en) * | 2020-07-13 | 2024-07-17 | Ajou University Industry-Academic Cooperation Foundation | Composition for preventing or treating inflammatory bowel disease |
| JP7535174B2 (ja) * | 2020-08-14 | 2024-08-15 | コバイオラブス，インコーポレーテッド | フィーカリバクテリウムプラウスニッツィ菌株およびその用途 |
| JP7570506B2 (ja) * | 2020-09-28 | 2024-10-21 | シージェイ バイオサイエンス， インク． | 微生物を含む炎症性疾患の診断または治療用組成物 |
| CN112402459B (zh) * | 2020-10-27 | 2023-01-31 | 江南大学 | 普拉梭菌缓解过敏性哮喘和鼻炎Th2反应中的应用 |
| KR102245415B1 (ko) * | 2020-12-14 | 2021-04-29 | 주식회사 엔테로바이옴 | 피칼리박테리움 프로스니치 균주 배양 배지 조성물 |
| EP4166150A1 (en) | 2021-10-15 | 2023-04-19 | Exeliom Biosciences | Association of a faecalibacterium prausnitzii strain and anti-pd-1, anti-pd-l1 or anti-ctla-4 antibodies for the treatment of cancer |
| EP4389134A1 (en) * | 2022-12-20 | 2024-06-26 | Exeliom Biosciences | Faecalibacterium prausnitzii strain cncm i-4573 for the treatment and prevention of clostridioides difficile infection |
| CN118845848B (zh) * | 2024-07-01 | 2025-10-17 | 温州大学 | 普氏粪杆菌dsm 17677在制备防治猪流行性腹泻病毒感染产品中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2015011700A (es) * | 2013-03-05 | 2016-07-20 | Univ Groningen | Uso de la bacteria faecalibacterium prausnitzii htf-f (dsm 26943) para suprimir la inflamacion. |
| WO2016075294A1 (en) * | 2014-11-13 | 2016-05-19 | Institut National De La Recherche Agronomique (Inra) | Faecalibacterium prausnitzii strains for treating and preventing gastrointestinal pain |
-
2016
- 2016-01-25 FR FR1650567A patent/FR3046934B1/fr active Active
-
2017
- 2017-01-23 WO PCT/EP2017/051306 patent/WO2017129515A1/fr not_active Ceased
- 2017-01-23 EP EP17702322.3A patent/EP3407902B1/fr active Active
- 2017-01-23 NZ NZ744528A patent/NZ744528A/en unknown
- 2017-01-23 SG SG11201806361PA patent/SG11201806361PA/en unknown
- 2017-01-23 PL PL17702322T patent/PL3407902T3/pl unknown
- 2017-01-23 ES ES17702322T patent/ES2820338T3/es active Active
- 2017-01-23 AU AU2017211244A patent/AU2017211244B2/en active Active
- 2017-01-23 US US16/072,319 patent/US10918678B2/en active Active
- 2017-01-23 CA CA3012214A patent/CA3012214C/fr active Active
- 2017-01-23 JP JP2018557200A patent/JP6935632B2/ja active Active
- 2017-01-23 LT LTEP17702322.3T patent/LT3407902T/lt unknown
- 2017-01-23 PT PT177023223T patent/PT3407902T/pt unknown
- 2017-01-23 CN CN201780019735.0A patent/CN109310714A/zh active Pending
- 2017-01-23 HU HUE17702322A patent/HUE050810T2/hu unknown
-
2018
- 2018-07-24 IL IL260752A patent/IL260752B/en active IP Right Grant
- 2018-08-10 ZA ZA201805302A patent/ZA201805302B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019508486A5 (enExample) | ||
| JP6444358B2 (ja) | ペディオコッカスを含有する医薬組成物および消化器症候群の症状を低減する方法 | |
| De Vries et al. | Lactobacillus plantarum—survival, functional and potential probiotic properties in the human intestinal tract | |
| Engevik et al. | Biochemical features of beneficial microbes: foundations for therapeutic microbiology | |
| JP5889191B2 (ja) | コレステロール低下剤としてのラクトバチルス・プランタルム菌株 | |
| Saulnier et al. | Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods | |
| CA2787544C (en) | Probiotic composition for use in the treatment of bowel inflammation | |
| Lin et al. | Immune effect of heat‐killed multistrain of Lactobacillus acidophilus against Salmonella typhimurium invasion to mice | |
| Elshaghabee et al. | Mitigation of antibiotic resistance using probiotics, prebiotics and synbiotics. A review | |
| Jeronymo-Ceneviva et al. | Probiotic properties of lactic acid bacteria isolated from water-buffalo mozzarella cheese | |
| EP3341001B1 (en) | Composition and method for treatment and prophylaxis of intestinal infection and inflammation | |
| Jonganurakkun et al. | Pediococcus pentosaceus NB-17 for probiotic use | |
| US20200121740A1 (en) | Pharmaceutical compositions containing pediococcus and methods for reducing the symptoms of gastroenterological syndromes | |
| RU2011139211A (ru) | Бактериальные штаммы, обладающие высокой противовоспалительной активностью | |
| Furtado et al. | Bacteriocinogenic Lactococcus lactis subsp: lactis DF04Mi isolated from goat milk: Evaluation of the probiotic potential | |
| Elshaghabee et al. | Dietary management by probiotics, prebiotics and synbiotics for the prevention of antimicrobial resistance | |
| JP6723980B2 (ja) | 大腸炎抑制剤 | |
| Onyenweaku et al. | Research Article Health Benefits of Probiotics | |
| JP2015533484A5 (enExample) | ||
| JP2015151385A (ja) | 経口感染症の予防治療剤、及び該予防治療剤を含有する医薬品、機能性食品または飲食品添加物 | |
| JP5172104B2 (ja) | ハンセン病発症予防作用のある菌体含有組成物 | |
| Combrinck et al. | Probiotics and Prebiotics | |
| WO2025005237A1 (ja) | 腸内菌叢でのＦｕｓｏｂａｃｔｅｒｉｕｍ属菌の制御用組成物及びその利用 | |
| Combrinck et al. | Probiotics and prebiotics | |
| Engevik et al. | Biochemical features of |